Federal grantmaking could get a lot more political soon under a recently released executive order (EO) that signals a break from science-driven health research. Learn more about the major changes that come with this EO and how researchers can navigate a new funding landscape: https://lnkd.in/e324_kVi

If this EO affects you and you’re looking for guidance on how to align your proposals with these new directives while maintaining scientific integrity, sign up for AcademyHealth’sz newest online course “Communicating to Build Trust”: https://bit.ly/3I4cZjr

ISPOR EU 2025 | Glasgow, Scotland November 9 - 12 | Explore health economics at ISPOR EU -- network with leaders, learn new methods, and stay updated on global policies.

Federal grantmaking could get a lot more political soon under a recently released executive order (EO) that signals a break from science-driven health research. Learn more about the major changes that come with this EO and how researchers can navigate a new funding landscape: https://lnkd.in/e324_kVi

If this EO affects you and you’re looking for guidance on how to align your proposals with these new directives while maintaining scientific integrity, sign up for AcademyHealth’sz newest online course “Communicating to Build Trust”: https://bit.ly/3I4cZjr

ISPOR EU 2025 | Glasgow, Scotland November 9 - 12 | Explore health economics at ISPOR EU -- network with leaders, learn new methods, and stay updated on global policies.

GBD 2023 results and impact: Gain an in-depth understanding of the latest data on mortality, morbidity, risk factors, and health disparities. Discuss how these results can inform current and future health policy.  
 Instructor: Katrin Burkart   

November 10, 7:00–8:30 a.m. PT; Register  

    November 18, 12:00–1:30 p.m. PT; Register  

    December 2, 7:00–8:30 p.m. PT; Register  

    December 9, 7:00–8:30 a.m. PT; Register  

TEFCA Readiness: Empowering Health Plans to Lead in Interoperability Presented by Surescripts Monday, November 10 | 1:00 PM – 2:00 PM ET   Whether you're new to the Trusted Exchange Framework and Common Agreement (TEFCA) or planning active participation, this session will equip you to navigate the transformation and define your strategic role in the evolving health information ecosystem. Join Surescripts to gain a clear understanding of its development, current status, and future direction—plus practical tools to assess your organization’s readiness.

Learn More and Register Today

Federal grantmaking could get a lot more political soon under a recently released executive order (EO) that signals a break from science-driven health research. Learn more about the major changes that come with this EO and how researchers can navigate a new funding landscape: https://lnkd.in/e324_kVi

If this EO affects you and you’re looking for guidance on how to align your proposals with these new directives while maintaining scientific integrity, sign up for AcademyHealth’sz newest online course “Communicating to Build Trust”: https://bit.ly/3I4cZjr

ISPOR EU 2025 | Glasgow, Scotland November 9 - 12 | Explore health economics at ISPOR EU -- network with leaders, learn new methods, and stay updated on global policies.

ERS Vision Live | 11 November
Pulmonary toxicity
Register your free place

Registration is open for the next ERS Vision Live panel discussion, hosted exclusively on the ERS Respiratory Channel.   Taking place on 11 November, this instalment will see an expert panel discuss pulmonary toxicity. The panellists will discuss key areas, including:   • when to suspect drug-induced lung toxicity; • radiological features of drug-induced lung toxicity; • drug-induced lung toxicity during lung cancer therapies. The event is completely free to access but registration is required. Learn more and register now Co-chairs: Prof. Vincent Cottin Vincent is Professor of Respiratory Medicine and Coordinator of the National Reference Center for Rare Pulmonary Diseases at the Louis Pradel Hospital and the University of Lyon, France. His research interests include rare ‘orphan’ pulmonary diseases. He is currently an associate editor of the European Respiratory Journal. Prof. Paolo Spagnolo Paolo is a full professor of respiratory medicine at the University of Padua, Italy; and Director of the Respiratory Unit at the University Hospital of Padua. His main research interests include interstitial lung disease (ILD) and sarcoidosis with emphasis on genetic predisposition, prediction of disease behaviour, and clinical trials of novel therapies. Speakers:

Dr Nazia Chaudhuri Nazia is a respiratory physician with a specialist interest in ILD. She is a senior clinical lecturer at Ulster University, Northern Ireland, United Kingdom. She is also a member of the ERS ILD Long-Range Planning Committee and was recently appointed Secretary of the ERS Assembly 12 (ILD) Idiopathic Interstitial Pneumonia Group. Dr Sara Piciucchi Sara is a doctor at the Radiology Department of G.B. Morgagni-Pierantoni Hospital in Forlì, Italy. She completed several fellowships and observerships in chest and cardiovascular imaging at leading institutions. She also serves as Secretary of the ERS Assembly 14 (Clinical Techniques, Imaging and Endoscopy) Imaging Group. Prof. Philippe Bonniaud Philippe is a professor of respiratory medicine and heads the “Institut Universitaire du Poumon” of Dijon University Hospital, France. He conducts research on ILD, with a specific focus on drug-induced lung diseases. From 2015–2018, he was Chair of ERS Assembly 3 (Basic and Translational Sciences) Molecular Pathology and Functional Genomics Group. Register your free place ERS Vision Live: Pulmonary toxicity 11 November, 2025 | 18:00–19:00 CET

We are pleased to invite you to the Psychiatry Update: Focus on Autism, Psychotic Disorders and Mood Disorders, a virtual CME meeting with renowned faculty and informative presentations on schizophrenia, MDD, and bipolar disorder, as well as innovative treatments and how to implement them into practice.

Our interactive conference center makes participating in the live virtual sessions and Q&As easy. We know that connecting with colleagues is crucial; our forums make it seamless to network, share ideas, and catch up with colleagues around the world.

All of this is in service of what matters most – taking home the kind of breakthroughs that can make a difference in your patients’ lives. This is a one-of-a-kind experience for the psychiatry community that you won’t want to miss - a taste of our annual Psychiatry Update, which returns in March 2026!

Register today for this innovative event! We look forward to you joining us on November 11-12, 2025!

AGENDA

Agenda subject to change. All times are in Eastern Time.

DAY 1, Tuesday, November 11, 2025

6:00 pm — 7:00 pm

Non-CME/CE Bonus Presentation

7:00 pm - 7:05 pm | Conference Welcome
Christoph U. Correll, MD
7:05 pm - 7:50 pm | Treating Schizophrenia Today
Christoph U. Correll, MD
7:50 pm - 8:00 pm | Audience Q&A
Christoph U. Correll, MD

8:05 pm — 8:55 pm

Non-CME/CE Bonus Presentation

8:55 pm - 9:40 pm | Navigating the Spectrum: Providing Mental Health Care for Adults with Autism
Jeremy Veenstra-VanderWeele, MD
9:40 pm - 9:55 pm | Audience Q&A
Christoph U. Correll, MD
Jeremy Veenstra-VanderWeele, MD

9:55 pm

Day One Adjourns

DAY 2, Wednesday, November 12, 2025

6:00 pm — 7:00 pm

Non-CME/CE Bonus Presentation

7:00 pm - 7:05 pm | Day Two Welcome
Leslie Citrome, MD, MPH
7:05 pm - 7:50 pm | Treating Mood Disorders Today
Holly A. Swartz, MD
7:50 pm - 8:00 pm | Audience Q&A
Leslie Citrome, MD, MPH
Holly A. Swartz, MD

8:05 pm — 8:55 pm

Non-CME/CE Bonus Presentation

8:55 pm - 9:40 pm | Common Comorbidities in Mood Disorders
Joseph F. Goldberg, MD
9:40 pm - 9:55 pm | Audience Q&A
Leslie Citrome, MD, MPH
Joseph F. Goldberg, MD

9:55 pm

Conference Adjourns

FACULTY

Leslie Citrome, MD, MPH

Christoph U. Correll, MD

Joseph F. Goldberg, MD

Holly A. Swartz, MD

Jeremy Veenstra-VanderWeele, MD

TARGET AUDIENCE

This conference is designed for psychiatrists, neurologists, primary care physicians, nurse practitioners, nurses, physician assistants, pharmacists, and other healthcare professionals who provide care to patients with psychiatric conditions.

LEARNING OBJECTIVES

As a result of participating in this live activity, participants should be able to:

• Describe innovations in the treatment of psychotic disorders.
• Identify and describe the core characteristics and diagnostic criteria of autism spectrum disorders (ASD) in adults, including understanding the variations in presentation compared to childhood diagnoses.
• Demonstrate competence in their ability to identify and diagnose mood disorders.
• Define and describe the concept of dual diagnosis, including the prevalence and impact of co-occurring substance use disorders (SUD) and mental health disorders in adults.

JOINT ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credits™.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 4.0 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on certificates.

Continuing Physician Assistants Education

Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

                                     Upcoming Webinar

Trust, Transparency & AI:
Modernizing Evidence Pipelines for Regulatory and HEOR Teams            
               
Join global experts transforming how evidence moves from research to regulation on Tuesday, November 11 at 11am EDT / 4pm GMT.
Click here or on the button below to register for this virtual event and gain insights on real-world regulatory and HEOR initiatives to modernize evidence pipelines.
       
About the Event

Evidence is growing faster than regulators, reviewers, and manufacturers can keep up. Let's explore how trustworthy AI and transparent workflows are redefining how evidence moves from research to regulation - cutting review times while maintaining rigor and reproducibility.
       Featuring:

• Sue Lacey Bryant, former Chief Knowledge Officer for England’s National Health Service (NHS)
• Dr. Rhodri Saunders, Founding Director of Coreva Scientific
• Eitan Agai, Founder of PICO Portal

   
What You'll Learn

• Where AI adds value - and where human judgment remains essential
• How transparent pipelines build trust with regulators and reviewers
• Real examples of faster, auditable evidence workflows

Register Free

       
Date: Tuesday, Nov 11th    
Time: 11:00am EDT (New York) / 4pm GMT (UK)
Can't make it live? Register to receive a copy of the recording.
    Don’t miss this opportunity to discover how AI-enabled workflows can accelerate regulatory submissions while strengthening transparency and scientific rigor!

Learning Opportunities: Knowledge & Regulations

Join PICO Portal on Tuesday, November 11 at 11am EST / 4pm GMT for an expert-led discussion on the critical role of systematic literature reviews (SLRs) in meeting regulatory standards for medical device and diagnostic manufacturers.
   Thought leaders Sue Lacey Bryant, former Chief Knowledge Officer for England’s National Health Service (NHS) and Dr. Rhodri Saunders, Founding Director of Coreva Scientific, will explore how today’s technology can address the growing challenges in regulatory evidence generation, making compliance faster, more transparent, and scientifically robust.
  Accelerating Regulatory Submissions:
Practical AI Workflows for MDR and IVDR Compliance            
               
How are medical device and diagnostic manufacturers meeting evolving regulatory standards through AI-enabled systematic literature review workflows? Explore this topic with the experts and gain real-world insights for enhancing transparency, traceability, and speed across regulatory submissions.
                Secure your spot for our upcoming webinar on Tuesday, November 11 at 11am EDT / 4pm GMT!
       
About the Event

As regulatory expectations for evidence continue to evolve, frameworks like MDR and IVDR are setting new standards for compliance across the healthcare landscape.
   Join Sue Lacey Bryant, former Chief Knowledge Officer for England’s National Health Service (NHS), Dr. Rhodri Saunders, Founding Director of Coreva Scientific, and Eitan Agai, Founder of PICO Portal, for a curated session on practical, AI-assisted approaches to regulatory-grade literature reviews.
   You’ll see how SLR platforms like PICO Portal can help streamline evidence generation - cutting review cycle times, improving audit readiness, and maintaining “living” updates aligned with MDR and IVDR requirements.
   
What You'll Learn

• How to plan, execute, and maintain regulatory-grade literature reviews with automation and AI
• Best practices for ensuring traceability and audit readiness
• Ways to reduce review cycle times while maintaining compliance
• Insights from NHS and Coreva Scientific leaders on modernizing evidence workflows

Register Free

Federal grantmaking could get a lot more political soon under a recently released executive order (EO) that signals a break from science-driven health research. Learn more about the major changes that come with this EO and how researchers can navigate a new funding landscape: https://lnkd.in/e324_kVi

If this EO affects you and you’re looking for guidance on how to align your proposals with these new directives while maintaining scientific integrity, sign up for AcademyHealth’sz newest online course “Communicating to Build Trust”: https://bit.ly/3I4cZjr

ISPOR EU 2025 | Glasgow, Scotland November 9 - 12 | Explore health economics at ISPOR EU -- network with leaders, learn new methods, and stay updated on global policies.

We are pleased to invite you to the Psychiatry Update: Focus on Autism, Psychotic Disorders and Mood Disorders, a virtual CME meeting with renowned faculty and informative presentations on schizophrenia, MDD, and bipolar disorder, as well as innovative treatments and how to implement them into practice.

Our interactive conference center makes participating in the live virtual sessions and Q&As easy. We know that connecting with colleagues is crucial; our forums make it seamless to network, share ideas, and catch up with colleagues around the world.

All of this is in service of what matters most – taking home the kind of breakthroughs that can make a difference in your patients’ lives. This is a one-of-a-kind experience for the psychiatry community that you won’t want to miss - a taste of our annual Psychiatry Update, which returns in March 2026!

Register today for this innovative event! We look forward to you joining us on November 11-12, 2025!

AGENDA

Agenda subject to change. All times are in Eastern Time.

DAY 1, Tuesday, November 11, 2025

6:00 pm — 7:00 pm

Non-CME/CE Bonus Presentation

7:00 pm - 7:05 pm | Conference Welcome
Christoph U. Correll, MD
7:05 pm - 7:50 pm | Treating Schizophrenia Today
Christoph U. Correll, MD
7:50 pm - 8:00 pm | Audience Q&A
Christoph U. Correll, MD

8:05 pm — 8:55 pm

Non-CME/CE Bonus Presentation

8:55 pm - 9:40 pm | Navigating the Spectrum: Providing Mental Health Care for Adults with Autism
Jeremy Veenstra-VanderWeele, MD
9:40 pm - 9:55 pm | Audience Q&A
Christoph U. Correll, MD
Jeremy Veenstra-VanderWeele, MD

9:55 pm

Day One Adjourns

DAY 2, Wednesday, November 12, 2025

6:00 pm — 7:00 pm

Non-CME/CE Bonus Presentation

7:00 pm - 7:05 pm | Day Two Welcome
Leslie Citrome, MD, MPH
7:05 pm - 7:50 pm | Treating Mood Disorders Today
Holly A. Swartz, MD
7:50 pm - 8:00 pm | Audience Q&A
Leslie Citrome, MD, MPH
Holly A. Swartz, MD

8:05 pm — 8:55 pm

Non-CME/CE Bonus Presentation

8:55 pm - 9:40 pm | Common Comorbidities in Mood Disorders
Joseph F. Goldberg, MD
9:40 pm - 9:55 pm | Audience Q&A
Leslie Citrome, MD, MPH
Joseph F. Goldberg, MD

9:55 pm

Conference Adjourns

FACULTY

Leslie Citrome, MD, MPH

Christoph U. Correll, MD

Joseph F. Goldberg, MD

Holly A. Swartz, MD

Jeremy Veenstra-VanderWeele, MD

TARGET AUDIENCE

This conference is designed for psychiatrists, neurologists, primary care physicians, nurse practitioners, nurses, physician assistants, pharmacists, and other healthcare professionals who provide care to patients with psychiatric conditions.

LEARNING OBJECTIVES

As a result of participating in this live activity, participants should be able to:

• Describe innovations in the treatment of psychotic disorders.
• Identify and describe the core characteristics and diagnostic criteria of autism spectrum disorders (ASD) in adults, including understanding the variations in presentation compared to childhood diagnoses.
• Demonstrate competence in their ability to identify and diagnose mood disorders.
• Define and describe the concept of dual diagnosis, including the prevalence and impact of co-occurring substance use disorders (SUD) and mental health disorders in adults.

JOINT ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credits™.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 4.0 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on certificates.

Continuing Physician Assistants Education

Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Webinar | 12 November
Journal Club – Optimising pleural infection treatment: lessons from TORPIDS-2
Register

Learn how to use GBD Compare: This session will offer interactive, hands-on instruction focused on navigating and using the GBD Compare visualization tool to explore GBD 2023 data and estimates.
Instructor: Emilie Maddison	October 30, 7:00–8:30 p.m. PT; Register      November 12, 7:00–8:30 a.m. PT; Register      December 11, 7:00–8:30 a.m. PT; Register
Instructor: Cesar Montalvo	November 20, 12:00–1:30 p.m. PT; Register      December 4, 7:00–8:30 p.m. PT; Register

GIN North America will be hosting a webinar looking at: A Feasibility Study on Digitizing the AAO-HNSF’s Clinical Practice Guideline on Ménière’s Disease. All are welcome to attend and you can register here: https://tinyurl.com/ymk6rz3d 

The Webinar will take place on November 12th at 1pm ET

Reinventing Credentialing and Monitoring Compliance with Shared Models & Agentic AI Presented by Sutherland Global Wednesday, November 12 | 2:00 PM – 3:00 PM ET   Reimagine payer credentialing with AI, automation, and a unique multi-payer shared model. Join Sutherland and Everest Group to uncover how next-gen technologies streamline credentialing, cut costs without reducing staff, and improve compliance. Learn how multi-payer shared models minimize provider touchpoints, reduce credentialing cycle time, and deliver better provider and member experiences.

Learn More and Register Today

Federal grantmaking could get a lot more political soon under a recently released executive order (EO) that signals a break from science-driven health research. Learn more about the major changes that come with this EO and how researchers can navigate a new funding landscape: https://lnkd.in/e324_kVi

If this EO affects you and you’re looking for guidance on how to align your proposals with these new directives while maintaining scientific integrity, sign up for AcademyHealth’sz newest online course “Communicating to Build Trust”: https://bit.ly/3I4cZjr

The 14th WFH Global Forum returns to Montreal from November 13 to14, 2025 at the William Gray Hotel. This unique meeting will bring together global experts, healthcare professionals, policymakers, and advocates to explore the latest in bleeding disorder care—all through the lens of equitable access to safe and sustainable treatment worldwide. VIEW FULL PROGRAM Highlights of the program include:                                                              Safety and surveillance updates Bias and gaps in women’s care Advances in von Willebrand disease (VWD) Rebalancing agents and emerging therapies The impact of artificial intelligence on hemophilia care Access to gene therapy and global availability of products                                 Don’t miss this opportunity to join conversations that are shaping the future of treatment:                                 REGISTER NOW

Building Real-World Integrations with the Trisotech Digital Enterprise Suite

November 13, 2025 09:30 AM

Dive into the technical capabilities of the Trisotech Digital Enterprise Suite (DES) in this in-depth webinar designed for makers, developers, architects, and integration specialists.We'll explore key integration points that enable you to seamlessly connect, extend, and automate within and beyond the Trisotech ecosystem. Topics include:•    Leveraging the DES and Automation APIs for advanced orchestration•    Calling external REST services and managing service responses•    Consuming and producing events to enable event-driven architectures•    Creating your own DMN custom FEEL functions to deliver extended capabilities•    Integrating and customizing dynamically generated forms with JavaScript and CSS •    Using emitters to feed external governance systems•    Leveraging existing data structures and models through the Digital Enterprise Graph (a semantic graph)•    Deploying using Digital Distributed Containers (DDC) for complete control over your automationThis session will combine practical demonstrations with architectural insights to help you make the most of Trisotech’ s extensibility features. Whether you are already using the Digital Enterprise Suite or considering it, this webinar will provide the technical foundation you need to succeed in your integration.

https://streamyard.com/watch/yrBYqcxMez5m

Interpreting GBD measures and metrics: This session will offer comprehensive guidance on understanding and interpreting the various measures and metrics used in the GBD study — DALYs, YLLs, YLDs, and other relevant health metrics.
Instructor: Annie Haakenstad	November 19, 12:00–1:30 p.m. PT; Register      December 10, 7:00–8:30 a.m. PT; Register
Instructor: David Pigott	November 13, 7:00–8:30 a.m. PT; Register      December 3, 7:00–8:30 p.m. PT; Register

Glecaprevir and Pibrentasvir’s Expansion to Acute Hepatitis C Virus Presented by AbbVie Thursday, November 13 | 2:00 PM – 3:00 PM ET   Acute Hepatitis C Virus (HCV) infection occurs within the first 6 months and is often asymptomatic, making it hard to diagnose early. It primarily affects marginalized populations with limited access to care. Join AbbVie to see how early intervention with Mavyret (G/P), an FDA-approved therapy, is key to supporting disease elimination and improving outcomes before progression to chronic complications.

Learn More and Register Today

Federal grantmaking could get a lot more political soon under a recently released executive order (EO) that signals a break from science-driven health research. Learn more about the major changes that come with this EO and how researchers can navigate a new funding landscape: https://lnkd.in/e324_kVi

If this EO affects you and you’re looking for guidance on how to align your proposals with these new directives while maintaining scientific integrity, sign up for AcademyHealth’sz newest online course “Communicating to Build Trust”: https://bit.ly/3I4cZjr

The 14th WFH Global Forum returns to Montreal from November 13 to14, 2025 at the William Gray Hotel. This unique meeting will bring together global experts, healthcare professionals, policymakers, and advocates to explore the latest in bleeding disorder care—all through the lens of equitable access to safe and sustainable treatment worldwide. VIEW FULL PROGRAM Highlights of the program include:                                                              Safety and surveillance updates Bias and gaps in women’s care Advances in von Willebrand disease (VWD) Rebalancing agents and emerging therapies The impact of artificial intelligence on hemophilia care Access to gene therapy and global availability of products                                 Don’t miss this opportunity to join conversations that are shaping the future of treatment:                                 REGISTER NOW

Federal grantmaking could get a lot more political soon under a recently released executive order (EO) that signals a break from science-driven health research. Learn more about the major changes that come with this EO and how researchers can navigate a new funding landscape: https://lnkd.in/e324_kVi

If this EO affects you and you’re looking for guidance on how to align your proposals with these new directives while maintaining scientific integrity, sign up for AcademyHealth’sz newest online course “Communicating to Build Trust”: https://bit.ly/3I4cZjr

Federal grantmaking could get a lot more political soon under a recently released executive order (EO) that signals a break from science-driven health research. Learn more about the major changes that come with this EO and how researchers can navigate a new funding landscape: https://lnkd.in/e324_kVi

If this EO affects you and you’re looking for guidance on how to align your proposals with these new directives while maintaining scientific integrity, sign up for AcademyHealth’sz newest online course “Communicating to Build Trust”: https://bit.ly/3I4cZjr

Federal grantmaking could get a lot more political soon under a recently released executive order (EO) that signals a break from science-driven health research. Learn more about the major changes that come with this EO and how researchers can navigate a new funding landscape: https://lnkd.in/e324_kVi

If this EO affects you and you’re looking for guidance on how to align your proposals with these new directives while maintaining scientific integrity, sign up for AcademyHealth’sz newest online course “Communicating to Build Trust”: https://bit.ly/3I4cZjr

Celebration of the Decades - 2000s

Moore’s Framework for Evaluation of CME/CPD Outcomes and it’s Evolution 

November 17, 2025

12:00 PM - 1:00 PM ET

Free for SACME Members / $30 Non-Members

Session Overview

Join us for this series sessions as we continue to remember seminal publications in continuing medical education (CME) and continuing professional development (CPD) over the past 50 years. We will have a rare opportunity to revisit important literature and hold conversations with scholars who have made major contributions to our field.

The Outcomes Framework developed by Moore, Green, and Gallis 2009¹, often presented as a hierarchy or pyramid, provides a systematic way to plan CME/CPD activities and assess the impact of those CME/CPD activities on clinician knowledge, skills, and attitudes; clinician performance; patient health status; and/or population health. The 2009 paper expands on the framework described in Moore 2003² and adds elements of instructional design described in Moore 2008.³

The central message of the framework is that CME/CPD planners should use a "backward planning" approach to instructional design that starts with identifying a desired change in patient outcomes or physician performance and continuing to work backward to design an educational intervention more likely to achieve those outcomes. Interventions that are more likely to produce desired outcomes include opportunities for learners to (1) deliberately practice the capabilities they will need to achieve the desired outcomes and (2) receive expert feedback to monitor the development of those capabilities.

In this session, using a Q&A format, Don will share his story of how the “Moore’s Outcomes Framework” came to be and how his thinking evolved. You will have the opportunity to ask the questions you may have always wanted to ask him.

As always, we welcome your thoughts and perspectives and hope to see you engaged in our VJC.

Presenter

Don Moore, PhD

Professor of Medical Education and Administration, Emeritus

Vanderbilt University School of Medicine 

Host and Facilitator

Mila Kostic, CHCP, FACEHP

Federal grantmaking could get a lot more political soon under a recently released executive order (EO) that signals a break from science-driven health research. Learn more about the major changes that come with this EO and how researchers can navigate a new funding landscape: https://lnkd.in/e324_kVi

If this EO affects you and you’re looking for guidance on how to align your proposals with these new directives while maintaining scientific integrity, sign up for AcademyHealth’sz newest online course “Communicating to Build Trust”: https://bit.ly/3I4cZjr

An Overview of an Adjunctive Treatment for Major Depressive Disorder Presented by AbbVie Tuesday, November 18 | 2:00 PM – 3:00 PM ET   Major Depressive Disorder (MDD) is a prevalent and disabling condition, impacting quality of life and productivity across the US. Many MDD patients require augmentation of antidepressant treatment with an additional therapy, and adjunctive treatment with an atypical antipsychotic is a guideline-recommended option for appropriate MDD patients. Join us as AbbVie explores the burden of MDD and examines the role, efficacy, and safety of adjunctive therapies.

Learn More and Register Today

GBD 2023 results and impact: Gain an in-depth understanding of the latest data on mortality, morbidity, risk factors, and health disparities. Discuss how these results can inform current and future health policy.  
 Instructor: Katrin Burkart   

November 10, 7:00–8:30 a.m. PT; Register  

    November 18, 12:00–1:30 p.m. PT; Register  

    December 2, 7:00–8:30 p.m. PT; Register  

    December 9, 7:00–8:30 a.m. PT; Register  

Federal grantmaking could get a lot more political soon under a recently released executive order (EO) that signals a break from science-driven health research. Learn more about the major changes that come with this EO and how researchers can navigate a new funding landscape: https://lnkd.in/e324_kVi

If this EO affects you and you’re looking for guidance on how to align your proposals with these new directives while maintaining scientific integrity, sign up for AcademyHealth’sz newest online course “Communicating to Build Trust”: https://bit.ly/3I4cZjr

Decision Counseling as a Method to Facilitate Shared Decision Making

19 November, 2025

Join us as Dr. Ronald E. Myers (DSW, PhD, FSBM), Professor and Director at Thomas Jefferson University, presents Decision Counseling as a Method to Facilitate Shared Decision Making. The course will include a combination of didactic learning and interactive practice sessions using the Decision Counseling Guide©, a Qualtrics™- based tool that is based on the Analytic Hierarchy Processing and Preventive Health Model frameworks. The course will prepare learners to guide patients/clients through a structured conversation about a decision to be made that involves values elicitation, preference clarification, and action plan development. Learners will be able to: Educate patients about defined alternatives Elicit patient values that favor each option Determine the effect of the patient's top values on the options Determine the relative importance of the patient's values Clarify the patient’s personal preference related to the available options Identify the patient’s decision Develop a preference-sensitive action plan Meet the Faculty: Ronald E Myers, DSW, PhD, FSBM Professor and Director Thomas Jefferson University United States Dr. Ronald E. Myers received a D.S.W. in Social Welfare Policy in 1983 and a Ph.D. in Medical Sociology in 1989 from the University of Pennsylvania. In addition, Dr. Myers completed postdoctoral training in Behavioral Epidemiology at Fox Chase Cancer Center from 1983 to 1985. Dr. Myers conducted cancer prevention and control research in the Division of Cancer Control and Population Sciences at Fox Chase Cancer Center in Philadelphia from 1985 to 1994. In 1994, Dr. Myers joined the Kimmel Cancer Center at Thomas Jefferson University and established a Cancer Prevention and Control Program. In 2001, Dr. Myers was appointed Professor of Medicine, Department of Medicine, Division of Genetic and Preventive Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA. Dr. Myers has conducted cancer prevention, control, and population science research for over 20 years. He has been a principal investigator on a number of NIH-funded research grants and has numerous peer-reviewed publications in the field. His areas of expertise include patient adherence to cancer screening; physician follow-up of abnormal cancer screening test results; and informed and shared decision making in cancer screening, susceptibility testing and clinical trials participation. Currently, Dr. Myers leads a special populations project funded by the NCI Center for Reducing Cancer Health Disparities. 19 November, 2025 at 08.30 PDT | 11.30 EDT | 15.30 UTC | 17.30 CEST

Register Today

Tackling the Provider Data Challenge to Activate AI-Powered Care Guidance Presented by Kyruus Health Wednesday, November 19 | 2:00 PM – 3:00 PM ET   While 100% of payers surveyed by Kyruus agree that AI will have a significant impact on their steerage strategies, a fragmented provider data foundation is preventing effective adoption. Join Kyruus and a panel of industry experts as they unpack exclusive findings from a new survey of 100 health plan leaders. We’ll explore the crucial—and often overlooked—connection between data quality, AI adoption, and effective steerage.

Learn More and Register Today

Interpreting GBD measures and metrics: This session will offer comprehensive guidance on understanding and interpreting the various measures and metrics used in the GBD study — DALYs, YLLs, YLDs, and other relevant health metrics.
Instructor: Annie Haakenstad	November 19, 12:00–1:30 p.m. PT; Register      December 10, 7:00–8:30 a.m. PT; Register
Instructor: David Pigott	November 13, 7:00–8:30 a.m. PT; Register      December 3, 7:00–8:30 p.m. PT; Register

Federal grantmaking could get a lot more political soon under a recently released executive order (EO) that signals a break from science-driven health research. Learn more about the major changes that come with this EO and how researchers can navigate a new funding landscape: https://lnkd.in/e324_kVi

If this EO affects you and you’re looking for guidance on how to align your proposals with these new directives while maintaining scientific integrity, sign up for AcademyHealth’sz newest online course “Communicating to Build Trust”: https://bit.ly/3I4cZjr

20–21 November, 2025
Course
Pulmonary hypertension

November 20: Purchasing Power Under Pressure: Employers' and Unions' Perspectives on Rising Health Care Prices and the Role of Middlemen

As health care prices have continued to rise, employers and unions have looked for assistance to manage provider prices.   Many third-party organizations have provided services to manage these increasing costs, including third-party administrators, benefits consultants, point solution vendors, repricers, and reinsurers.   Join Health Affairs on November 20 for an open access virtual event with a panel of experts exploring insights and perspectives on rising prices, the ecosystem of third-party vendors, proposed legislation to improve transparency of these vendors, and more.   The event will draw upon articles in the Health Affairs Forefront series, “ Provider Prices in the Commercial Sector,” supported by Arnold Ventures.    Confirmed speakers include:  Patrick Pine, Robert F. Kennedy Medical Plan, Juan De La Cruz Pension Plan (retired) Andrea Caballero, Catalyst for Payment Reform Katie Gudiksen, UC Law in San Francisco  Health Affairs Senior Editor Laura Tollen will moderate.

Join Us

Improving Cancer Outcomes: Ensuring Access to Targeted Testing and Therapies Presented by Guardant Health Thursday, November 20 | 1:00 PM – 2:00 PM ET   Precision oncology is transforming cancer care and improving outcomes, but it comes with rising costs for health plans, employers, and patients. While testing is essential to guide effective use of targeted therapies, both remain underutilized. This webinar will explore the clinical and economic benefits of testing and targeted treatments, along with policy and management strategies that influence access and implementation.

Learn More and Register Today

Learn how to use GBD Compare: This session will offer interactive, hands-on instruction focused on navigating and using the GBD Compare visualization tool to explore GBD 2023 data and estimates.
Instructor: Emilie Maddison	October 30, 7:00–8:30 p.m. PT; Register      November 12, 7:00–8:30 a.m. PT; Register      December 11, 7:00–8:30 a.m. PT; Register
Instructor: Cesar Montalvo	November 20, 12:00–1:30 p.m. PT; Register      December 4, 7:00–8:30 p.m. PT; Register

20–21 November, 2025
Course
Pulmonary hypertension

Panel discussion on applications of routine health and administrative data for respiratory research 25 November, 2025 from 17:00–18:00 CET This ERS webinar, chaired by Dr Olena Gruzieva and Dr David Lo, will cover: Use of routine health data in paediatric respiratory research. Methodological considerations i.e. strengths/limitations of routine clinical data. Application of climate and environmental data to respiratory health research in children. Integrating large datasets to inform clinical care and public health. Opportunities and challenges in using population-based data to advance paediatric respiratory epidemiology.

Find out more and register

Webinar information Join us on November 25, for “Progress toward a cure for hemophilia: gene editing explained” a webinar which will cover how genetic technologies are creating new possibilities for hemophilia care. This event will take you beyond today’s gene therapies to explore the exciting field of gene editing, introducing key genetic concepts and technologies, and explaining how they work. It will also address common questions such as safety and treatment durability, and will cover what these advances could mean for the future of hemophilia care.

REGISTER NOW

Webinar title: 🧬 Progress toward a cure for hemophilia: gene editing explained Date: Tuesday, November 25, 2025 Time: 10:00 a.m. ET (Montreal time) Speaker: Glenn Pierce, Vice President, Medical, World Federation of Hemophilia (U.S.A.) Where: Zoom

   

Designed for both people with hemophilia and healthcare professionals, this event will make complex concepts clear and engaging. The webinar will conclude with an interactive Q&A session. Don’t miss this opportunity! We look forward to welcoming you to this informative and engaging webinar!

REGISTER NOW

25–27 November, 2025
Skills course
Interventional bronchoscopy

25–27 November, 2025
Skills course
Interventional bronchoscopy

27 November, 2025
Webinar
ERS/UNITE4TB webinar series: session four